[1] |
Monasterio G,Castillo F,Rojas L,et al.Th1/Th17/Th22 immune response and their association with joint pain, imagenological bone loss,RANKL expression and osteoclast activity in temporomandibular joint osteoarthritis:a preliminary report[J].J Oral Rehabil,2018,45(8):589-597.
|
[2] |
Voglis S,Moos S,Kloos L,et al.Regulation of IL-22BP in psoriasis[J].Sci Rep,2018,8(1):5085.
|
[3] |
Trifari S,Kaplan CD,Tran EH,et al.Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17,T(H)1 and T(H)2 cells[J].Nature,2009,10(8):864-871.
|
[4] |
Ciccia F,Guggino G,Rizzo A,et al.Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren′s syndrome and Sgren-associated non-Hodgkin lymphomas and is regulated by IL-18[J].Clin Exp Immunol,2015,181(2):219-229.
|
[5] |
Zhang L,Li YG,Li YH,et al.Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis[J].PloS one,2012,7(4):e31000.
|
[26] |
杨旭燕.Th22 细胞及细胞因子IL-22 在系统性红斑狼疮发病机制中的意义初探[D].杭州:浙江大学,2013.
|
[6] |
Wang R,Zeng YL,Qin HM,et al.Association of interleukin 22 gene polymorphisms and serum IL-22 level with risk of systemic lupus erythematosus in a Chinese population[J].Clin Exp Immunol,2018,193(2):143-151.
|
[7] |
Zerbini A,Muratore F,Boiardi L,et al.Increased expression of interleukin-22 in patients with giant cell arteritis[J].Rheumatology(Oxford),2018,57(1): 64-72.
|
[8] |
Wolk K,Witte E,Witte K,et al.Biology of interleukin-22[J].Semin Immunopathol,2010,32(1):17-31.
|
[9] |
Yi B,Cao J,Shi J,et al.Interleukin-22 promotes lung cancer cell proliferation and migration via the IL-22R1/STAT3 and IL-22R1/AKT signaling pathways[J].Mol Cell Biochem,2016,415(1-2):1-11.
|
[10] |
Alessandri C,Ciccia F,Priori R,et al.CD4 T lymphocyte autophagy is upregulated in the salivary glands of primary Sjgren′s syndrome patients and correlates with focus score and disease activity[J].Arthritis Res Ther,2017,19(1):178.
|
[11] |
Ciccia F,Guggino G,Rizzo A,et al.Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren′s syndrome[J].Ann Rheum Dis,2012,71(2):295-301.
|
[12] |
Lavoie TN,Stewart CM,Berg KM,et al.Expression of interleukin-22 in Sjren′s syndrome:significant correlatio n with disease parameters[J].Scand J Immunol,2011,74(4):377-382.
|
[13] |
Lavoie TN,Carcamo WC,Wanchoo A,et al.IL-22 regulation of functional gene expression in salivary gland cells[J].Genom Data,2015,7:178-184.
|
[14] |
Azizi G,Jadidi-Niaragh F.Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis[J].Int J Rheum Dis,2013,16(3):243-253.
|
[15] |
Zhong W,Zhao L,Liu T,et al.IL-22-producing CD4+T cells in the treatment response of rheumatoid arthritis to combination therapy with methotrexate and leflunomide[J].Sci Rep,2017,7:41 143.
|
[16] |
van der Geest T,Roeleveld DM,Walgreen B,et al.Imaging fibroblast activation protein to monitor therapeutic effects of neutralizing interleukin-22 in collagen-induced arthritis[J].Rheumatology(Oxford),2018,57(4):737-747.
|
[17] |
Zhao M,Li Y.Anti-apoptotic effect of interleukin-22 on fibroblast-like synoviocytes in patients with rheumatoid arthritis is mediated via the signal transducer and activator of transcription 3 signaling pathway[J].Int J Rheum Dis,2017,20(2):214-224.
|
[20] |
邵勤,高洪燕,周小莉,等.IL-22 在类风湿关节炎中的表达及临床意义[J].中国免疫学 杂志,2017,33(1):103-107.
|
[23] |
顾丽萍,杨贵丽,陈幼发,等.Th22 细胞及其功能分子IL-22 在狼疮性肾炎中的作用研究[J].中国免疫学杂志,2017,33(5):755-758.
|
[24] |
鄢海波,赵令,马宁,等.汉族人系统性红斑狼疮和狼疮肾炎与IL-22 受体基因多态性的关系[J].中国现代医学杂志,2017,27(9):44-48.
|
[18] |
Roeleveld DM,Koenders MI.The role of the Th17 cytokines IL-17 and IL-22 in rheumatoid arthritis pathogenesis and developments in cytokine immunotherapy[J].Cytokine,2015,74(1):101-107.
|
[19] |
Corneth Odilia BJ,Reijmers Rogier M,Mus Adriana MC,et al.Loss of IL-22 inhibits autoantibody formation in collagen-induced arthritis in mice[J].Eur J Immunol,2016,46(6):1404-1414.
|
[21] |
Kim KW,Kim HR,Park JY,et al.Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts[J].Arthritis Rheum,2012,64(4):1015-1023.
|
[22] |
Gupta S,Tatouli IP,Rosen LB,et al.Distinct functions of autoantibodies against interferon in systemic lupus erythematosus: a comprehensive analysis of anticytokine autoantibodies in common rheumatic diseases[J].Arthritis Rheum,2016,68(7):1677.
|
[25] |
El-Gazzar II,Bahgat DMR,Khateeb EME.IL-22 in Egyptian SLE patients,could it reflect disease activity,skin or renal involvement or is it only an expensive ESR?[J].Egypt Rheumatol,2017,39(1):13-18.
|
[27] |
Toussirot E,Laheurte C,Gaugler B,et al.Increased IL-22-and IL-17A-producing mucosal-associated invariant T cells in the peripheral blood of patients with ankylosing spondylitis[J].Front Immunol,2018,9:1610.
|
[28] |
Zhang X,Li X,Han R,et al.Copy number variations of the IL-22 gene are associated with ankylosing spondylitis:a case-control study in Chinese Han population[J].Hum immunol,2017,78(9):547-552.
|
[29] |
Resende G,Machado C,Macedo R,et al.FRI0013 IL-22 induces an increase in SFP3 expression by synovial fibroblasts in inflammatory joint diseases [J].Ann Rheum Dis,2016,75(Suppl 2):430.
|